Publications by authors named "Beth Ziegler"

Claim this Profile
D
Discovery of N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), a highly selective, orally bioavailable inhibitor of aurora kinases with activity against multidrug-resistant cancer cell lines.
Stephanie Geuns-Meyer, Victor J Cee, Holly L Deak, Bingfan Du, Brian L Hodous, Beth Ziegler

J Med Chem· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non-small-cell lung cancer xenograft models.
Angela Coxon, Beth Ziegler, Stephen Kaufman, Man Xu, Hongyu Wang

Mol Cancer· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines.
Marc Payton, Tammy L Bush, Grace Chung, Beth Ziegler, Patrick Eden

Cancer Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis